ImmunityBio, Inc. IBRX Tax on Share Settlement
Tax on Share Settlement at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s tax on share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s tax on share settlement?
- ImmunityBio, Inc. (IBRX) reported tax on share settlement of $6.99M in Q1 2026.
- How has ImmunityBio, Inc.'s tax on share settlement changed year-over-year?
- ImmunityBio, Inc.'s tax on share settlement increased by 481.9% year-over-year, from $1.2M to $6.99M.
- What is the long-term trend for ImmunityBio, Inc.'s tax on share settlement?
- Over 4 years (2021 to 2025), ImmunityBio, Inc.'s tax on share settlement has grown at a -13.6% compound annual growth rate (CAGR), from $4.06M to $2.27M.
- What does tax on share settlement mean?
- Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.